Institutional embeddedness and the strategic leeway of actors: The case of the German therapeutical biotech industry

Socio-Economic Review

Volumn 7, Issue 2, 2009, Pages 181-207

  Lange, Knut ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Germany; Institutional change; International competition; Labour market institutions; United Kingdom; Varieties of capitalism

Indexed keywords

EID: 64049094143     PISSN: 14751461     EISSN: 1475147X     Source Type: Journal    
DOI: 10.1093/ser/mwn029     Document Type: Article

References (38)

1. Ahrweiler, P., Gilbert, N. and Pyka, A. (2006) 'Institutions Matter but... - Organisational Alignment in Knowledge-based Industries', Science, Technology and Innovation Studies, 2, 39-58.
2. Adelberger, K. E. (2000) 'Semi-Sovereign Leadership? The State's Role in German Biotechnology and Venture Capital Growth', German Politics, 9, 103-122.
3. Allen, M. (2004) 'The Varieties-of-capitalism Paradigm: Not Enough Variety?', Socio-Economic Review, 2, 87-108.
4. Amable, B. (2003) The Diversity of Modern Capitalism, Oxford, Oxford University Press.
5. Avnimelech, G. and Teubal, M. (2006) 'Creating Venture Capital Industries that Co-evolve with High-tech: Insights from an Extended Life Cycle Perspective of the Israeli Experience', Research Policy, 35, 1477-1498.
6. Beyer, J. and Höpner, M. (2003) 'The Disintegration of Organized Capitalism: German Corporate Governance in the 1990s', West European Politics, 26, 179-198.
7. Black, B. S. and Gilson, R. J. (1998) 'Venture Capital and the Structure of Capital Markets: Banks Versus Stock Markets', Journal of Financial Economics, 47, 243-277.
8. Casper, S. (2000) 'Institutional Adaptiveness, Technology Policy, and the Diffusion of New Business Models: The Case of German Biotechnology', Organization Studies, 21, 887-914.
9. Casper, S. and Kettler, H. (2001) 'National Institutional Frameworks and the Hybridization of Entrepreneurial Business Models: The German and UK Biotechnology Sectors', Industry and Innovation, 8, 5-30.
10. Casper, S. and Murray, F. (2003) 'Commercialising science: How the organization of scientific labour markets impacts the development of biotech clusters', Proceedings of the Social Construction of Clusters Conference, Visby, Sweden.
11. Casper, S. and Whitley, R. (2004) 'Managing Competencies in Entrepreneurial Technology Firms: A Comparative Institutional Analysis of Germany, Sweden and the UK', Research Policy, 33, 89-106.
12. Crouch, C. (2005) Capitalist Diversity and Change: Recombinant Governance and Institutional Entrepreneurs, Oxford, Oxford University Press.
13. Deeg, R. and Jackson, G. (2007) 'Towards a More Dynamic Theory of Capitalist Diversity', Socio-Economic Review, 5, 149-179.
14. Ernst & Young (2001) Integration: European Life Sciences Report 2001 London, Ernst & Young International.
15. Ernst & Young (2002) Neue Chancen: Deutscher Biotechnologie - Report 2002, Mannheim, Ernst & Young AG Wirtschaftsprüfungsgesellschaft.
16. Ernst & Young (2004) Per Aspera Ad Astra. Der Steinige Weg zu den Sternen: Deutscher Biotechnologie - Report 2004, Mannheim, Ernst & Young AG Wirtschaftsprüfungsgesellschaft.
17. Ernst & Young (2005) Kräfte der Evolution: Deutscher Biotechnologie-Report 2005, Mannheim, Ernst & Young AG Wirtschaftsprüfungsgesellschaft.
18. Ernst & Young (2006) Zurück in die Zukunft: Deutscher Biotechnologie-Report 2006, Mannheim, Ernst & Young AG Wirtschaftsprüfungsgesellschaft.
19. Ernst & Young (2007) Verhaltene Zuversicht: Deutscher Biotechnologie-Report 2007, Mannheim, Ernst & Young AG Wirtschaftsprüfungsgesellschaft.
20. Etzkowitz, H. (2003) 'Public Venture Capital: The Secret life of US Science Policy'. In Biegelbauer, P. S. and Borras, S. (eds) Innovation policies in Europe and the US. The New Agenda, Aldershot, UK, Burlington, VT, Ashgate, pp. 43-60.
21. Hall, P. and Soskice, D. (2001) 'An Introduction to Varieties of Capitalism'. In Hall, P. and Soskice, D. (eds) Varieties of Capitalism: The Institutional Foundations of Comparative Advantage, Oxford, Oxford University Press, pp. 1-68.
22. Herrmann, A. M. (2009, forthcoming) One Political Economy, One Competitive Strategy? Comparing Pharmaceutical Firms in Germany, Italy, and the UK, Oxford, Oxford University Press.
23. Höpner, M. and Jackson, G. (2006) 'Revisiting the Mannesmann Takeover: How Markets for Corporate Control Emerge', European Management Review, 3, 142-155.
24. Lane, C. (2003) 'Changes in Corporate Governance of German Corporations: Convergence to the Anglo-Saxon Model?', Competition and Change, 7, 79-100.
25. Lerner, J. (1999) 'The Government as Venture Capitalist: The Long-Run Impact of the SBIR Program', The Journal of Business, 72/3, 285-318.
26. Lerner, J. and Gompers, P. (2001) 'The Venture Capital Revolution', Journal of Economic Perspectives, 15, 145-168.
27. Lerner, J. (2002) 'Venture Capital'. In Steil, B., Victor, D. G. and Nelson, R. R. (eds) Technological Innovation and Economic Performance Princeton, Princeton University Press, pp. 327-346.
28. Maier, A. (2004) 'Wellington gibt Wagnisfinanziers Hoffnung', Financial Times Deutschland, Hamburg, 18.
29. Martin, P. A. (2000) 'National Report of the United Kingdom'. In European Commission (ed) EUR 18886/3 - Inventory of Public Biotechnology R&D Programmes in Europe - Volume 3: National Reports: Italy, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, United Kingdom. Index', Luxembourg, Office for Official Publications of the European Communities, pp. UK1-UK61.
30. Martin, P. A. and Thomas, S. (1998) 'The "Commercialisation Gap" in Gene Therapy'. In Senker, J. and van Vliet, R. (eds) Biotechnology and Competitive Advantage. Europe's Firms and the US Challenge, Cheltenham, Edward Elgar, pp. 130-155.
31. Murray, G. C. and Lott, J. (1995) 'Have UK Venture Capitalists a Bias Against Investment in New Technology-Based Firms?', Research Policy 24, 283-299.
32. Nelson, R. R. and Rosenberg, N. (1993) 'Technical Innovation and National Systems'. In Nelson, R. R. (ed) National Innovation Systems. A Comparative Analysis, New York, Oxford, Oxford University Press, pp. 3-21.
33. Robbins-Roth, C. (2001) Zukunftsbranche Biotechnologie. Von der Alchemie zum Börsengang, Wiesbaden, Gabler.
34. Schneiberg, M. (2007) 'What's on the path? Path Dependence, Organizational Diversity and the Problem of Institutional Change in the US Economy, 1900-1950', Socio-Economic Review, 5, 47-80.
35. Scott, R. (2008) Institutions and Organizations. Ideas and Interests 3rd edition, Thousand Oaks, Sage.
36. Senker, J. (1996) 'National Systems of Innovation', Technovation, 16, 219-229.
37. Streeck, W. (1997) 'Beneficial Constraints: On the Economic Limits of Rational Voluntarism'. In Hollingsworth, J. R. and Boyer, R. (eds) Contemporary Capitalism: The Embeddedness of Institutions, Cambridge, UK, New York, NY, Cambridge University Press, pp. 197-219.
38. Streeck, W. and Thelen, K. (2005) 'Introduction: Institutional Change in Advanced Political Economies'. In Streeck, W. and Thelen, K. (eds) Beyond Continuity. Institutional Change in Advanced Political Economies Oxford, Oxford University Press, pp. 1-39.